The importance of prospective planning of pharmacokinetic trials. Considerations of studies on the phenytoin-digoxin-(P-D) and phenytoin-digitoxin-(P-DT) interaction.

Rameis, H

Rameis, H.

Affiliation

Rameis H; Arbeitsgruppe für Angewandte Klinische Pharmacokologie, Wien, Austria.

Int J Clin Pharmacol Ther Toxicol ; 30(11): 528-9, 1992 Nov.

Article in En | MEDLINE | ID: mdl-1490820

Subject(s)

Digoxin/pharmacology; Pharmacokinetics; Phenytoin/pharmacology; Research Design; Adult; Digitoxin/blood; Digitoxin/pharmacokinetics; Digoxin/pharmacokinetics; Humans; Male; Phenytoin/pharmacokinetics; Random Allocation; Single-Blind Method

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phenytoin / Research Design / Pharmacokinetics / Digoxin Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: Int J Clin Pharmacol Ther Toxicol Year: 1992 Document type: Article Affiliation country: Austria Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links